Howe & Rusling’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-105
| Closed | – | – | 807 |
|
2022
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 1155 |
|
2022
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 1132 |
|
2022
Q1 | $0 | Hold |
105
| – | – | ﹤0.01% | 1058 |
|
2021
Q4 | $0 | Hold |
105
| – | – | ﹤0.01% | 1047 |
|
2021
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 1013 |
|
2021
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 993 |
|
2021
Q1 | $0 | Hold |
105
| – | – | ﹤0.01% | 988 |
|
2020
Q4 | $0 | Hold |
105
| – | – | ﹤0.01% | 981 |
|
2020
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 852 |
|
2020
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 874 |
|
2020
Q1 | $0 | Hold |
105
| – | – | ﹤0.01% | 844 |
|
2019
Q4 | $0 | Hold |
105
| – | – | ﹤0.01% | 859 |
|
2019
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 854 |
|
2019
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 866 |
|
2019
Q1 | $0 | Hold |
105
| – | – | ﹤0.01% | 867 |
|
2018
Q4 | $0 | Hold |
105
| – | – | ﹤0.01% | 879 |
|
2018
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 892 |
|
2018
Q2 | $1K | Buy |
+105
| New | +$1K | ﹤0.01% | 763 |
|